Mark Elliott Boulding Ptc Therapeutics, Inc. (PTCT) insider trading activity

PTCT Quotes by TradingView

Mark Elliott Boulding is EXEC. VP AND CLO of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 103,901 shares of PTCT, which is worth approximately $5.18 Million. The most recent transaction as insider was on Jul 08, 2021, when has been sold 7,805 shares (Common Stock) at a price of $15.75 per share, resulting in proceeds of $122,929. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 104K
0% 3M change
12.46% 12M change
Total Value Held $5.18 Million

Mark Elliott Boulding Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 08 2021
BUY
Exercise of conversion of derivative security
$122,929 $15.75 p/Share
7,805 Added 13.55%
49,779 Common Stock
Feb 01 2021
SELL
Open market or private sale
$44,315 $56.96 p/Share
778 Reduced 1.58%
48,374 Common Stock
Jan 06 2021
BUY
Grant, award, or other acquisition
-
10,200 Added 17.19%
49,152 Common Stock
Jan 05 2021
SELL
Open market or private sale
$48,150 $62.37 p/Share
772 Reduced 1.94%
38,952 Common Stock
MEB

Mark Elliott Boulding

EXEC. VP AND CLO
South Plainfield, NJ

Track Institutional and Insider Activities on PTCT

Follow PTC THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

News

Receive news related to PTC THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PTCT